-
1741
Systemic Lupus Erythematosus Presenting as Anorexia Nervosa in a Middle‐Aged Woman: A Rare Case Report and Literature Review
Published 2025-01-01“…ABSTRACT Background Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multisystemic involvement and unclear etiology. …”
Get full text
Article -
1742
Methods of massive parallel reporter assays for investigation of enhancers
Published 2021-06-01“…Alterations of gene regulatory elements may cause various pathologies, including cancer, congenital disorders and autoimmune diseases. The development of high-throughput genomic assays has made it possible to significantly accelerate the accumulation of information about the characteristic epigenetic properties of regulatory elements. …”
Get full text
Article -
1743
Long-term antibody responses to COVAXIN and COVISHIELD vaccines in rheumatoid arthritis patients and healthy control population – A cross-sectional study
Published 2025-01-01“…Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation and damage in the joints. …”
Get full text
Article -
1744
Endocervical miRNA-142 expression in patients with pelvic inflammatory disease positive for Chlamydia trachomatis
Published 2024-01-01“…Changes in miRNA expression have been identified in many diseases, such as cardiac and autoimmune disorders, schizophrenia, and cancer. In this cross-sectional pilot investigation, samples were taken from control women who were not infected and from symptomatic women who were infected with C. trachomatis. …”
Get full text
Article -
1745
Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis
Published 2022-01-01“…Results. 377 (6.5%) patients underwent liver retransplantation. Autoimmune liver disease and hepatitis C virus (HCV) were the most common underlying diagnoses. …”
Get full text
Article -
1746
Mycophenolate mofetil: an update on its mechanism of action and effect on lymphoid tissue
Published 2025-01-01“…IntroductionMycophenolate mofetil (MMF) is an immunosuppressive drug administered in the management of both autoimmune diseases and organ transplantation. The main aims of the study were: (a) to obtain information regarding the safety of using MMF in respect of its effect on normal T and B cells in lymphoid tissues; (b) to investigate whether the generation of inducible Foxp3-expressing regulatory T cells (Treg) might constitute additional mechanisms underlying the immunosuppressive properties of MMF.MethodsThe effect of MMF (in vivo studies) and its active metabolite, mycophenolic acid, (in vitro studies) on murine CD4+ and CD8+ T cells as well as B cells was determined, regarding: (a) absolute count, proliferation and apoptosis of these cells (in vitro studies); (b) absolute count of these cells in the head and neck lymph nodes, mesenteric lymph nodes and the spleen (in vivo studies).ResultsThe study found that the treatment of mice with MMF induced depletion of CD4+ and CD8+ T cells and B cells in lymph nodes and the spleen, and the magnitude of these effects should be considered as clinically relevant. …”
Get full text
Article -
1747
Epidemiological, clinical and imaging profile of Multiple Sclerosis
Published 2021-12-01“…<p><strong>Background:</strong> multiple sclerosis is a neurological, autoimmune, degenerative, chronic and progressive demyelinating disease associated with different genetic and environmental factors.…”
Get full text
Article -
1748
DIABETES MELLITUS IN PATIENTS WITH LIVER CIRRHOSIS: NEW TREATMENT OPTIONS
Published 2017-09-01“…There are common mechanisms that provoke metabolic and autoimmune disorders in the development of chronic hepatitis and cirrhosis, leading to steatosis, insulin resistance, impaired glucose tolerance and the development of diabetes mellitus. …”
Get full text
Article -
1749
Case report: Rituximab combined with plasma exchange treatment for systemic lupus erythematosus complicated with thrombotic microangiopathy and non-cirrhotic portal hypertension
Published 2025-01-01“…The patient was negative for hepatitis virus, autoimmune liver disease antibodies, ceruloplasmin, and tumor markers. …”
Get full text
Article -
1750
-
1751
Lack of Antilipoprotein Lipase Antibodies in Takayasu's Arteritis
Published 2009-01-01Get full text
Article -
1752
Haemophagocytic Lymphohistiocytosis with Leptospirosis: A Rare but Devastating Complication
Published 2021-01-01“…Secondary haemophagocytic lymphohistiocytosis (sHLH), often associated with an array of infections, malignancies, and autoimmune diseases, is rarely seen with leptospirosis, which carries a relatively poor prognosis even with modern state-of-the-art medical care. …”
Get full text
Article -
1753
Atypical Sjögrenʼs Syndrome Initially Presenting as Lymphocytic Interstitial Pneumonitis followed by Immune Thrombocytopenia
Published 2021-01-01“…Sjögrenʼs syndrome is an autoimmune disease characterized primarily by decreased exocrine gland function leading to eye and mouth dryness. …”
Get full text
Article -
1754
Profiling Serum Cytokines and Anticytokine Antibodies in Psoriasis Patients
Published 2022-01-01“…Anticytokine autoantibodies (ACAAs) were detected in various autoimmune diseases but remained largely unknown in psoriasis. …”
Get full text
Article -
1755
CLINICAL CHARACTERISTICS OF DEBUT AND RISK FACTORS OF PEDIATRIC MULTIPLE SCLEROSIS
Published 2024-11-01“…Risk factors for MS: family history of MS and autoimmune diseases (AID) in 25 %, obesity in 25 %, concomitant AIDS in 10 %. …”
Get full text
Article -
1756
Characterization of novel human endogenous retrovirus structures on chromosomes 6 and 7
Published 2025-01-01“…We examined a cohort of 222 individuals for HML-2 proviruses 6q14.1 and 7p22.1a, two loci that are capable of producing full-length viral proteins and have been previously implicated in several cancers, autoimmune disorders and neurodegenerative diseases, using long-read DNA sequencing. …”
Get full text
Article -
1757
-
1758
Safety, Tolerability, and Pharmacokinetics of NIM‐1324 an Oral LANCL2 Agonist in a Randomized, Double‐Blind, Placebo‐Controlled Phase I Clinical Trial
Published 2025-01-01“…ABSTRACT NIM‐1324 is an oral investigational new drug for autoimmune disease that targets the Lanthionine Synthetase C‐like 2 (LANCL2) pathway. …”
Get full text
Article -
1759
Disputable issues of the surgical strabismus correction in patients with Graves’ ophthalmopathy
Published 2022-11-01“…Korchemkina<sup>2</sup> </p> <p> <sup>1</sup>Central Clinical Hospital and Polyclinic of the Department for Presidential Affairs, Moscow, Russian Federation </p> <p> <sup>2</sup>Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical Biological Agency of Russian Federation, Moscow, Russian Federation </p> <p> Graves’ ophthalmopathy (GO) is an autoimmune disease characterized by lymphocytic infiltration, fibroblast activation and the accumulation of collagen and glycosaminoglycans in the orbital tissues and extraocular muscles. …”
Get full text
Article -
1760
RNAI-MEDIATED SILENCING OF MATRIX METALLOPROTEINASE 1 IN EPIDERMAL KERATINOCYTES INFLUENCES THE BIOLOGICAL EFFECTS OF INTERLEUKIN 17A
Published 2018-07-01“…Matrix metalloproteinases (MMPs) are important for the pathogenesis of psoriasis and other autoimmune disorders. In the extracellular matrix, accumulation of proinflammatory cytokines, such as interleukin 17A (IL-17A), leads to induction of several MMPs, including MMP1. …”
Get full text
Article